| Income Statement |
| Total Revenue | 238.15M |
|
| Revenues (USD) | 238.15M |
| Cost of Revenue | 9.69M |
| Gross Profit | 228.46M |
| Operating Expenses | 237.92M |
| Research and Development Expense | 10.44M |
| Selling, General and Administrative Expense | 197.86M |
| Operating Income | -9.46M |
| Interest Expense | 5.33M |
| Income Tax Expense | -717.00K |
| Net Income | -8.98M |
| Net Income Common Stock | -8.98M |
| Net Income Common Stock (USD) | -8.98M |
| Consolidated Income | -8.98M |
| Earnings per Basic Share | -0.22 |
| Earnings per Basic Share (USD) | -0.22 |
| Earnings per Diluted Share | -0.22 |
| Earning Before Interest & Taxes (EBIT) | -4.36M |
| Earning Before Interest & Taxes (USD) | -4.36M |
| Weighted Average Shares | 40.10M |
| Balance Sheet |
| Cash and Equivalents | 244.58M |
| Cash and Equivalents (USD) | 244.58M |
| Trade and Non-Trade Receivables | 37.37M |
| Current Assets | 313.30M |
| Property, Plant & Equipment Net | 101.37M |
| Total Assets | 1.63B |
| Total Debt | 471.39M |
| Current Liabilities | 209.20M |
| Debt Non-Current | 471.39M |
| Total Liabilities | 710.54M |
| Accumulated Retained Earnings (Deficit) | -159.86M |
| Accumulated Other Comprehensive Income | 5.76M |
| Shareholders Equity | 914.72M |
| Shareholders Equity (USD) | 914.72M |
| Assets Non-Current | 1.31B |
| Total Debt (USD) | 471.39M |
| Deferred Revenue | 21.00M |
| Goodwill and Intangible Assets | 1.06B |
| Liabilities Non-Current | 501.34M |
| Trade and Non-Trade Payables | 35.07M |
| Tax Assets | 125.32M |
| Tax Liabilities | 1.46M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 16.61M |
| Net Cash Flow from Financing | -25.54M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -59.12M |
| Capital Expenditure | -15.69M |
| Issuance (Repayment) of Debt Securities | -23.74M |
| Net Cash Flow from Investing | -15.69M |
| Net Cash Flow from Operations | -17.90M |
| Effect of Exchange Rate Changes on Cash | 17.00K |
| Share Based Compensation | 2.75M |